Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of the RSV monoclonal antibody RSM01 in healthy adults has completed with results posted. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSM01

Snippet

Sponsor: Gates Medical Research Institute | Conditions: RSV Infection | Phase 1 | Status: COMPLETED | Results posted: 2024-05-20